Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery-Reference-Cited by-同舟云学术

Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery

Published:2022-03 Issue: Volume:142 Page:105183
ISSN:0010-4825
Container-title:Computers in Biology and Medicine
language:en
Short-container-title:Computers in Biology and Medicine

Author:

Ray Abhik Kumar^ORCID,Sen Gupta Parth Sarthi,Panda Saroj Kumar,Biswal Satyaranjan,Bhattacharya Uddipan,Rana Malay Kumar^ORCID

Publisher

Elsevier BV

Subject

Health Informatics,Computer Science Applications

Reference59 articles.

1. A novel coronavirus from patients with pneumonia in China, 2019;Zhu;N. Engl. J. Med.,2020

2. Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19;Muralidharan;J. Biomol. Struct. Dyn.,2020

3. Perspectives: potential therapeutic options for SARS-CoV-2 patients based on feline infectious peritonitis strategies: central nervous system invasion and drug coverage;Olsen;Int. J. Antimicrob. Agents,2020

4. A pneumonia outbreak associated with a new coronavirus of probable bat origin;Zhou;Nature,2020

5. In silico studies of Potency and safety assessment of selected trial drugs for the treatment of COVID-19;Adegbola;In Silico Pharmacol,2021

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zanamivir and baloxavir combination to cure persistent influenza and coronavirus infections after hematopoietic stem cell transplant;International Journal of Antimicrobial Agents;2024-09

2. Assessing the impact of MSH3 and MSH6 polymorphisms on lung cancer risk in North Indian patients undergoing platinum chemotherapy through molecular dynamics simulation;Scientific Reports;2024-07-13

3. Structural and functional impacts of neonicotinoids analogues on Apis mellifera's chemosensory protein: Insights from spectroscopic and molecular modeling investigations;International Journal of Biological Macromolecules;2024-07

4. 3-Chymotrypsin-like Protease (3CLpro) of SARS-CoV-2: Validation as a Molecular Target, Proposal of a Novel Catalytic Mechanism, and Inhibitors in Preclinical and Clinical Trials;Viruses;2024-05-24

5. Harnessing Brazilian biodiversity database: identification of flavonoids as potential inhibitors of SARS-CoV-2 main protease using computational approaches and all-atom molecular dynamics simulation;Frontiers in Chemistry;2024-02-22